Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $72,695 | 53 | 59.9% |
| Consulting Fee | $26,775 | 29 | 22.1% |
| Travel and Lodging | $11,745 | 92 | 9.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,350 | 5 | 4.4% |
| Food and Beverage | $4,310 | 147 | 3.6% |
| Education | $526.99 | 26 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $60,427 | 96 | $0 (2024) |
| Myriad Women's Health, Inc. | $56,461 | 131 | $0 (2023) |
| Applied Medical Resources Corporation | $1,098 | 3 | $0 (2022) |
| Astellas Pharma US Inc | $475.87 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $475.57 | 6 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $360.43 | 13 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $332.66 | 23 | $0 (2020) |
| AbbVie Inc. | $257.26 | 7 | $0 (2023) |
| TherapeuticsMD, Inc. | $239.40 | 11 | $0 (2021) |
| Organon Llc | $190.23 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,503 | 60 | Myriad Genetic Laboratories, Inc. ($16,714) |
| 2023 | $64,578 | 164 | Myriad Women's Health, Inc. ($56,461) |
| 2022 | $28,590 | 48 | Myriad Genetic Laboratories, Inc. ($27,051) |
| 2021 | $9,244 | 18 | Myriad Genetic Laboratories, Inc. ($9,092) |
| 2020 | $280.02 | 12 | AMAG Pharmaceuticals, Inc. ($123.95) |
| 2019 | $598.52 | 25 | AbbVie, Inc. ($163.80) |
| 2018 | $332.42 | 13 | AstraZeneca Pharmaceuticals LP ($129.84) |
| 2017 | $276.36 | 12 | Cogentix Medical Inc. ($96.33) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena, Skyla | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Womens Health | ||||||
| 11/09/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $127.80 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: OB/GYN | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $33.20 | General |
| Category: Biological | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $142.39 | General |
| Category: Biological | ||||||
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $100.06 | General |
| 09/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $44.95 | General |
| 08/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Biological | ||||||
| 08/01/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Honoraria | In-kind items and services | $175.00 | General |
| Category: ONCOLOGY | ||||||
| 07/18/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Hematology | ||||||
| 07/13/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $120.63 | General |
| Category: ONCOLOGY | ||||||
| 07/13/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $31.02 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Honoraria | In-kind items and services | $2,800.00 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $189.00 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $56.07 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $43.18 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $23.63 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $503.15 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Travel and Lodging | In-kind items and services | $216.08 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.50 | General |
| 05/28/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.77 | General |
| Category: Biological | ||||||
| 05/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: DIABETES | ||||||
| 04/26/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Honoraria | In-kind items and services | $175.00 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.75 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 359 | 455 | $106,016 | $38,477 |
| 2022 | 6 | 401 | 494 | $114,360 | $43,330 |
| 2021 | 6 | 281 | 335 | $73,917 | $27,588 |
| 2020 | 10 | 343 | 401 | $83,551 | $28,800 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 189 | $52,920 | $19,751 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 154 | $30,492 | $10,073 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $14,760 | $5,073 | 34.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 60 | 60 | $5,160 | $2,714 | 52.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,684 | $865.85 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 131 | 172 | $48,160 | $18,359 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 164 | $32,472 | $11,924 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 63 | 63 | $22,680 | $7,913 | 34.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 62 | 62 | $5,332 | $2,741 | 51.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $4,148 | $1,586 | 38.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 16 | 16 | $1,568 | $805.55 | 51.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 121 | $33,033 | $12,593 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 100 | $19,300 | $7,023 | 36.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $15,356 | $5,442 | 35.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 16 | 16 | $3,744 | $1,229 | 32.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 27 | 27 | $2,322 | $1,208 | 52.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 27 | $162.00 | $93.96 | 58.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 92 | 108 | $27,432 | $8,823 | 32.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 105 | $18,480 | $6,106 | 33.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 31 | 31 | $11,718 | $4,167 | 35.6% |
| 77067 | Mammography of both breasts | Office | 2020 | 30 | 30 | $7,625 | $3,754 | 49.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 39 | 39 | $3,627 | $1,786 | 49.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $4,769 | $1,396 | 29.3% |
| 76641 | Ultrasound of one breast | Office | 2020 | 13 | 13 | $4,972 | $1,233 | 24.8% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 22 | 22 | $3,498 | $821.43 | 23.5% |
About Dr. Candace Westgate, DO
Dr. Candace Westgate, DO is a Obstetrics & Gynecology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1669607735.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Candace Westgate, DO has received a total of $121,402 in payments from pharmaceutical and medical device companies, with $17,503 received in 2024. These payments were reported across 352 transactions from 33 companies. The most common payment nature is "Honoraria" ($72,695).
As a Medicare-enrolled provider, Westgate has provided services to 1,384 Medicare beneficiaries, totaling 1,685 services with total Medicare billing of $138,194. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Indianapolis, IN
- Active Since 05/19/2009
- Last Updated 02/27/2025
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1669607735
Products in Payments
- MYRISK (Device) $79,345
- myRisk (Device) $32,514
- BRACAnalysis (Device) $1,750
- GELPOINT V-PATH (Device) $1,098
- BRAC CDx (Device) $1,050
- GENESIGHT (Device) $1,050
- myChoice CDx (Device) $700.00
- LYNPARZA (Drug) $388.63
- MYCHOICE CDX (Device) $350.00
- Veozah (Drug) $332.02
- INTRAROSA (Drug) $281.11
- Orilissa (Drug) $210.77
- NEXPLANON (Drug) $204.96
- IMVEXXY (Drug) $135.71
- PreciseTumor (Device) $129.26
- ANNOVERA (Drug) $103.69
- Mirena (Drug) $97.88
- Urgent PC (Device) $96.33
- MYFEMBREE (Drug) $86.03
- Kyleena (Drug) $83.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Indianapolis
Michelle Owens, Md, MD
Obstetrics & Gynecology — Payments: $116,117
Maryann Chimhanda, Md, MD
Obstetrics & Gynecology — Payments: $10,533
Ms. Colleen Mcdermott, M.d, M.D
Obstetrics & Gynecology — Payments: $8,015
David Murphy, D.o, D.O
Obstetrics & Gynecology — Payments: $6,197
Karla Loken, Do, DO
Obstetrics & Gynecology — Payments: $5,772
Kay Eigenbrod, Md, MD
Obstetrics & Gynecology — Payments: $5,734